García Fernández, LorenaRomero Ferreiro, VerónicaPeñuelas Calvo, InmaculadaÁlvarez Mon, Miguel ÁngelScala, MauroRomero Ferreiro, CarmenJiménez López, EstelaSantos, José LuisRodríguez Jiménez, Roberto2024-12-102024-12-102024García-Fernández, L., Romero-Ferreiro, V., Peñuelas-Calvo, I., Álvarez-Mon, M. A., Scala, M., Romero-Ferreiro, C., López, E. J., Santos, J. L., & Rodriguez-Jimenez, R. (2024). Cariprazine and cognition in patients with schizophrenia and bipolar disorder: A systematic review. Harvard Review of Psychiatry, 32(6), 207-217. https://doi.org/10.1097/HRP.00000000000004111067-3229http://hdl.handle.net/11268/13335Cariprazine (CAR), an antipsychotic with partial agonism at the D3 receptor and higher affinity than dopamine, has shown significant procognitive effects in preclinical animal studies. This study systematically reviews CAR's effects on cognitive measures in patients with schizophrenia and bipolar disorder.spaAttribution 4.0 Internationalhttps://creativecommons.org/licenses/by/4.0/Cariprazine and Cognition in Patients with Schizophrenia and Bipolar Disorder: A Systematic Reviewjournal article10.1097/HRP.0000000000000411open accessPsiquiatríaPsicosisPublicación científicaGoal 3: Ensure healthy lives and promote well-being for all at all ages